MeSH term
Frequency | Condition_Probility | Animals | 85 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cell Culture Techniques | 2 | 0.0 |
Humans | 245 | 0.0 |
*Membrane Proteins | 3 | 0.0 |
Myelin Basic Proteins/analysis | 2 | 7.0 |
Myelin P0 Protein/analysis | 2 | 66.0 |
Myelin Sheath/*chemistry | 3 | 50.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
Rats | 25 | 0.0 |
Research Support, Non-U.S. Gov't | 199 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics/pathology | 9 | 64.0 |
Comparative Study | 25 | 0.0 |
Gene Expression | 7 | 0.0 |
Mice | 56 | 0.0 |
Myelin Proteins/*genetics | 71 | 68.0 |
Myelin Sheath/physiology | 3 | 16.0 |
Nerve Fibers/pathology | 2 | 8.0 |
Axons/physiology | 3 | 6.0 |
Charcot-Marie-Tooth Disease/genetics/*physiopathology | 2 | 66.0 |
Disease Progression | 3 | 0.0 |
Myelin Proteins/genetics | 37 | 68.0 |
Male | 100 | 0.0 |
Middle Aged | 42 | 0.0 |
Neural Conduction | 13 | 13.0 |
Peripheral Nerves/pathology/physiopathology | 2 | 50.0 |
Phenotype | 30 | 0.0 |
Sequence Deletion | 5 | 0.0 |
Adult | 54 | 0.0 |
Age Factors | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Female | 95 | 0.0 |
Myelin Proteins/genetics/metabolism | 2 | 50.0 |
Nerve Regeneration/physiology | 2 | 8.0 |
Schwann Cells/cytology/*metabolism | 3 | 50.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics | 42 | 30.0 |
Gene Dosage | 11 | 2.0 |
Gene Duplication | 18 | 11.0 |
Point Mutation/genetics | 3 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 40 | 0.0 |
Adolescent | 26 | 0.0 |
Charcot-Marie-Tooth Disease/genetics/*pathology | 4 | 66.0 |
Child | 31 | 0.0 |
Child, Preschool | 16 | 0.0 |
DNA/chemistry/genetics | 3 | 0.0 |
DNA Mutational Analysis | 19 | 0.0 |
Family Health | 7 | 0.0 |
Infant | 4 | 0.0 |
Mutation | 15 | 0.0 |
Pedigree | 44 | 0.0 |
Sural Nerve/pathology/ultrastructure | 3 | 33.0 |
Aged | 18 | 0.0 |
Autoantibodies/*blood | 3 | 1.0 |
Cauda Equina/immunology | 2 | 66.0 |
Chromosomes, Human, Pair 17 | 23 | 7.0 |
Gene Deletion | 14 | 0.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Myelin Sheath/*pathology | 3 | 33.0 |
Myelin Sheath/*metabolism | 4 | 10.0 |
*Gene Expression Regulation | 6 | 0.0 |
Hela Cells | 6 | 0.0 |
Point Mutation | 21 | 1.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
X Chromosome | 6 | 1.0 |
Infant, Newborn | 2 | 0.0 |
Disease Models, Animal | 7 | 0.0 |
Mutation/*genetics | 8 | 0.0 |
Myelin Proteins/*genetics/metabolism | 4 | 66.0 |
Peripheral Nerves/metabolism/pathology/*physiopathology | 2 | 100.0 |
Heterozygote | 10 | 0.0 |
Mutation/genetics | 6 | 0.0 |
Myelin P0 Protein/*genetics | 15 | 51.0 |
Nerve Fibers, Myelinated/pathology | 3 | 23.0 |
Sural Nerve/pathology | 13 | 30.0 |
Amino Acid Sequence | 29 | 0.0 |
Molecular Sequence Data | 50 | 0.0 |
Sequence Alignment | 4 | 0.0 |
DNA/chemistry | 2 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 5 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Base Sequence | 36 | 0.0 |
Brain Stem/physiopathology | 2 | 25.0 |
Charcot-Marie-Tooth Disease/*genetics/pathology/physiopathology | 4 | 44.0 |
Connexins/genetics | 13 | 28.0 |
Linkage (Genetics) | 6 | 0.0 |
Mutation, Missense | 4 | 0.0 |
Neural Conduction/physiology | 6 | 15.0 |
X Chromosome/*genetics | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Myelin Proteins/biosynthesis/*genetics | 3 | 75.0 |
Protein Binding/genetics | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Transfection | 9 | 0.0 |
DNA Mutational Analysis/*methods | 3 | 2.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Genetic Screening/*methods | 2 | 1.0 |
Sensitivity and Specificity | 2 | 0.0 |
Amino Acid Substitution | 7 | 0.0 |
DNA Primers | 6 | 0.0 |
Exons | 12 | 0.0 |
Genes, Dominant | 9 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*genetics/physiopathology | 2 | 28.0 |
Cohort Studies | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 6 | 0.0 |
*Gene Frequency | 2 | 0.0 |
Polymerase Chain Reaction | 19 | 0.0 |
Animals, Genetically Modified | 5 | 2.0 |
Microscopy, Electron | 18 | 0.0 |
Myelin Proteins/*genetics/*metabolism | 3 | 100.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
Sural Nerve/ultrastructure | 3 | 42.0 |
*Genes, Recessive | 3 | 2.0 |
Reference Values | 4 | 0.0 |
Sural Nerve/metabolism/pathology | 2 | 22.0 |
Charcot-Marie-Tooth Disease/classification/*genetics | 5 | 33.0 |
Chromosomes, Human, Pair 17/*genetics | 8 | 4.0 |
Gene Frequency/genetics | 2 | 0.0 |
Genetic Screening | 4 | 0.0 |
Genotype | 13 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*genetics | 21 | 48.0 |
Myelin P0 Protein/genetics | 11 | 73.0 |
Guillain-Barre Syndrome/*immunology | 2 | 100.0 |
Myelin Proteins/genetics/*immunology | 2 | 100.0 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology | 2 | 100.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
Connexins/*genetics | 14 | 8.0 |
Electrophysiology | 8 | 1.0 |
*Point Mutation | 19 | 1.0 |
Chromosomes, Human, Pair 17/genetics | 3 | 1.0 |
*Evolution, Molecular | 2 | 0.0 |
*Gene Duplication | 8 | 5.0 |
Recombination, Genetic | 2 | 0.0 |
Paralysis/*genetics | 9 | 75.0 |
Pressure | 10 | 7.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Charcot-Marie-Tooth Disease/diagnosis/*genetics | 3 | 25.0 |
Demyelinating Diseases/*genetics/pathology | 2 | 50.0 |
Gene Expression Regulation | 4 | 0.0 |
Mice, Transgenic | 7 | 0.0 |
Schwann Cells/*cytology/metabolism | 2 | 50.0 |
Charcot-Marie-Tooth Disease/*diagnosis/genetics | 2 | 40.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Demyelinating Diseases/genetics | 4 | 100.0 |
English Abstract | 9 | 0.0 |
Nervous System Diseases/*genetics | 6 | 19.0 |
Amino Acid Substitution/*genetics | 3 | 4.0 |
Biopsy | 11 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*genetics/pathology | 5 | 62.0 |
Ulnar Nerve/physiopathology | 2 | 40.0 |
Genetic Techniques | 2 | 2.0 |
Hereditary Motor and Sensory Neuropathies/*diagnosis/*genetics | 2 | 100.0 |
Bone Neoplasms/*genetics | 3 | 6.0 |
*Chromosome Aberrations | 3 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
Chromosomes, Human, Pair 12 | 3 | 1.0 |
*Gene Amplification | 4 | 1.0 |
Osteosarcoma/*genetics | 3 | 9.0 |
Mutation, Missense/genetics | 2 | 1.0 |
Sural Nerve/pathology/physiopathology/ultrastructure | 2 | 100.0 |
Nerve Regeneration/*physiology | 2 | 7.0 |
Peripheral Nervous System/*physiology | 2 | 28.0 |
Chromosome Mapping | 19 | 0.0 |
*Chromosomes, Human, Pair 17 | 18 | 3.0 |
*Gene Deletion | 3 | 0.0 |
Norway | 2 | 1.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Peripheral Nervous System Diseases/*genetics | 7 | 28.0 |
Polymorphism, Genetic | 6 | 0.0 |
Hereditary Motor and Sensory Neuropathies/genetics | 4 | 50.0 |
*Mutation, Missense | 3 | 0.0 |
Serine/*genetics | 2 | 10.0 |
Demyelinating Diseases/*genetics/pathology/physiopathology | 2 | 66.0 |
Cell Line | 5 | 0.0 |
Endoplasmic Reticulum/metabolism | 3 | 1.0 |
Immunohistochemistry | 17 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Lod Score | 3 | 0.0 |
*Membrane Glycoproteins | 3 | 0.0 |
Membrane Proteins/genetics | 4 | 1.0 |
Polymorphism, Single-Stranded Conformational | 14 | 0.0 |
*Mutation | 16 | 0.0 |
Biological Markers/analysis | 2 | 0.0 |
Genetic Predisposition to Disease | 6 | 0.0 |
Myelin Proteins/analysis/*genetics | 3 | 100.0 |
Polymerase Chain Reaction/*methods | 3 | 0.0 |
COS Cells | 4 | 0.0 |
Cells, Cultured | 8 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Models, Molecular | 4 | 0.0 |
Protein Structure, Tertiary/genetics | 3 | 1.0 |
Protein Transport | 3 | 0.0 |
Schwann Cells/cytology/metabolism | 3 | 33.0 |
In Situ Hybridization | 3 | 0.0 |
Myelin Proteins/genetics/*metabolism | 2 | 50.0 |
Sciatic Nerve/metabolism | 5 | 35.0 |
Sural Nerve/metabolism | 2 | 50.0 |
Tissue Distribution | 5 | 0.0 |
Cell Cycle | 3 | 0.0 |
Gene Expression Regulation, Neoplastic/*genetics | 2 | 1.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Myelin Sheath/metabolism | 2 | 9.0 |
Time Factors | 5 | 0.0 |
Circular Dichroism | 2 | 0.0 |
Peroxisomes/*metabolism | 2 | 7.0 |
Protein Biosynthesis | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Schwann Cells/metabolism | 3 | 12.0 |
3T3 Cells | 5 | 0.0 |
Cloning, Molecular | 10 | 0.0 |
Dinucleotide Repeats | 2 | 2.0 |
Sequence Analysis, DNA | 7 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Mice, Neurologic Mutants | 10 | 9.0 |
Myelin P0 Protein/deficiency/*genetics/physiology | 2 | 100.0 |
Myelin Proteins/deficiency/*genetics/physiology | 2 | 100.0 |
Transcription Factors/*genetics | 4 | 0.0 |
Charcot-Marie-Tooth Disease/genetics | 10 | 41.0 |
Prospective Studies | 3 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics/*pathology | 6 | 66.0 |
Schwann Cells/pathology | 3 | 23.0 |
Sural Nerve/*pathology | 2 | 40.0 |
Cell Count | 3 | 0.0 |
X Chromosome/genetics | 2 | 1.0 |
Case-Control Studies | 4 | 0.0 |
Miller Fisher Syndrome/immunology | 2 | 100.0 |
Myelin Proteins/*immunology | 2 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Cell Division | 5 | 0.0 |
Myelin Sheath/pathology/ultrastructure | 2 | 50.0 |
Schwann Cells/*pathology/ultrastructure | 2 | 100.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Cell Division/genetics | 2 | 0.0 |
Myelin P0 Protein/metabolism | 2 | 50.0 |
Mice, Nude | 3 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Charcot-Marie-Tooth Disease/*diagnosis/*genetics | 4 | 66.0 |
Charcot-Marie-Tooth Disease/*genetics/*physiopathology | 3 | 33.0 |
Myelin Proteins/*genetics/physiology | 4 | 80.0 |
Myelin P0 Protein/physiology | 2 | 100.0 |
Schwann Cells/pathology/physiology | 2 | 100.0 |
Charcot-Marie-Tooth Disease/*genetics/physiopathology | 7 | 53.0 |
Charcot-Marie-Tooth Disease/classification/*genetics/physiopathology | 2 | 50.0 |
Axons/ultrastructure | 2 | 9.0 |
Schwann Cells/ultrastructure | 2 | 25.0 |
Biological Markers | 2 | 0.0 |
Glioma/*genetics | 2 | 2.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Myelin-Associated Glycoprotein/analysis | 2 | 40.0 |
Chromosomes, Human, Pair 1 | 4 | 1.0 |
Genetic Markers | 11 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Diagnosis, Differential | 3 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*diagnosis/genetics | 2 | 66.0 |
Myelin Sheath/ultrastructure | 2 | 20.0 |
Point Mutation/*genetics | 3 | 1.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Conserved Sequence | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Phylogeny | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Muscle, Skeletal/innervation | 2 | 22.0 |
Peripheral Nerves/*pathology | 2 | 18.0 |
Electromyography | 4 | 2.0 |
*Phenotype | 4 | 1.0 |
Bone Neoplasms/*genetics/pathology | 2 | 16.0 |
Osteosarcoma/*genetics/pathology | 2 | 22.0 |
*ATP-Binding Cassette Transporters | 2 | 1.0 |
Haplotypes | 3 | 0.0 |
Myelin Proteins/chemistry/*genetics | 6 | 100.0 |
Myelin P0 Protein/chemistry/*genetics | 3 | 60.0 |
Scoliosis/genetics | 2 | 33.0 |
*Gene Dosage | 5 | 5.0 |
DNA/*analysis | 2 | 0.0 |
*Genes, Dominant | 3 | 1.0 |
RNA, Messenger/biosynthesis | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Rabbits | 3 | 0.0 |
Age of Onset | 6 | 0.0 |
Action Potentials/physiology | 2 | 4.0 |
*Frameshift Mutation | 4 | 2.0 |
Heterozygote Detection | 3 | 0.0 |
*X Chromosome | 3 | 0.0 |
Forskolin/pharmacology | 2 | 0.0 |
Multigene Family/genetics | 3 | 2.0 |
Myelin Proteins/biosynthesis/genetics | 3 | 50.0 |
DNA Primers/genetics | 6 | 0.0 |
Charcot-Marie-Tooth Disease/complications/*genetics | 2 | 50.0 |
Chromosome Aberrations | 4 | 0.0 |
Biotin | 2 | 3.0 |
Multigene Family | 13 | 1.0 |
Blotting, Southern | 4 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
*Multigene Family | 6 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Membrane Glycoproteins/chemistry/*genetics | 2 | 5.0 |
*Receptors, Cell Surface | 5 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Antigens/analysis | 2 | 1.0 |
Charcot-Marie-Tooth Disease/*pathology | 2 | 50.0 |
Schwann Cells/immunology/*pathology | 2 | 66.0 |
DNA/genetics | 4 | 0.0 |
Myelin Proteins/*biosynthesis/*genetics | 2 | 100.0 |
*Neural Conduction | 2 | 10.0 |
Restriction Mapping | 3 | 0.0 |
Genes, Recessive | 2 | 0.0 |
Cell Compartmentation | 2 | 0.0 |
Charcot-Marie-Tooth Disease/*metabolism/pathology | 2 | 66.0 |
Nerve Compression Syndromes/genetics | 2 | 50.0 |
Paralysis/genetics | 4 | 80.0 |
Charcot-Marie-Tooth Disease/*metabolism/*pathology | 2 | 100.0 |
Myelin Proteins/*metabolism | 4 | 20.0 |
Schwann Cells/*metabolism/pathology | 2 | 40.0 |
Microscopy, Confocal | 3 | 0.0 |
Microsatellite Repeats | 3 | 0.0 |
Species Specificity | 5 | 0.0 |
*Membrane Transport Proteins | 2 | 0.0 |
DNA, Complementary/*genetics | 2 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Membrane Proteins/*genetics | 5 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Retinoids/pharmacology | 2 | 9.0 |
Aged, 80 and over | 4 | 0.0 |
Genetic Diseases, Inborn/*genetics | 2 | 3.0 |
*Homozygote | 2 | 1.0 |
Neural Conduction/genetics | 3 | 33.0 |
Behavior, Animal/physiology | 2 | 7.0 |
Mice, Transgenic/*genetics | 2 | 6.0 |
DNA, Complementary | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Axons | 2 | 14.0 |
Charcot-Marie-Tooth Disease/classification/diagnosis/*genetics | 2 | 66.0 |
Peripheral Nervous System Diseases/diagnosis/genetics | 2 | 100.0 |
Sex Factors | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Alleles | 4 | 0.0 |
Myelin Proteins/chemistry/*genetics/metabolism | 2 | 100.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
DNA, Antisense | 2 | 5.0 |
Schwann Cells/physiology | 2 | 33.0 |
Neurologic Examination | 2 | 1.0 |
DNA | 2 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
Action Potentials | 2 | 3.0 |
Axons/pathology | 2 | 6.0 |
Muscle, Skeletal/physiopathology | 2 | 10.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Japan | 2 | 0.0 |
Protease Inhibitors/pharmacology | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
